Course Detail
Course Description
| Course | Code | Semester | T+P (Hour) | Credit | ECTS |
|---|---|---|---|---|---|
| MOLECULAR ONCOLOGY | MMBY1211563 | Spring Semester | 2+0 | 2 | 6 |
| Course Program |
| Prerequisites Courses | |
| Recommended Elective Courses |
| Language of Course | English |
| Course Level | Second Cycle (Master's Degree) |
| Course Type | Elective |
| Course Coordinator | Assoc.Prof. Nihal KARAKAŞ |
| Name of Lecturer(s) | Assoc.Prof. Nihal KARAKAŞ, Assist.Prof. Yasemin YOZGAT BYRNE |
| Assistant(s) | |
| Aim | The aim of this course is to define and evaluate the fundamental concepts in cancer biology and therapy, understanding of the basis for cancer formation, progression and recurrence as well as learning about current and prospective therapies against cancers. |
| Course Content | This course contains; Introduction to cancer biology ,Oncogenes-I,Oncogenes-II,Signaling Factors and Cancer-I,Signaling Factors and Cancer-II,Tumor Suppressor Genes-I,Tumor Suppressor Genes-II,Carcinogenesis,Metastasis,Tumor Immunology and Immunotherapy,Targeted Therapy for Cancer and Clinical Phase Trials,Stem Cell Therapeutics for Cancer,Lipid Metabolism in Cancer. |
| Course Learning Outcomes | Teaching Methods | Assessment Methods |
| Defines the cancer, explain fundamentals of cancer, define and discuss the molecular basis of cancer, explain the current tretament strategies in cancer therapies, define and discuss the barriers in cancer therapies, analyze and discuss the new therapy approaches against cancers. | 10, 13, 14, 16, 19, 37, 9 | A, B, C, E, K |
| Teaching Methods: | 10: Discussion Method, 13: Case Study Method, 14: Self Study Method, 16: Question - Answer Technique, 19: Brainstorming Technique, 37: Computer-Internet Supported Instruction, 9: Lecture Method |
| Assessment Methods: | A: Traditional Written Exam, B: Short Answer Exam, C: Multiple-Choice Exam, E: Homework, K: Self Assessment Technique |
Course Outline
| Order | Subjects | Preliminary Work |
|---|---|---|
| 1 | Introduction to cancer biology | |
| 2 | Oncogenes-I | |
| 3 | Oncogenes-II | |
| 4 | Signaling Factors and Cancer-I | |
| 5 | Signaling Factors and Cancer-II | |
| 6 | Tumor Suppressor Genes-I | |
| 7 | Tumor Suppressor Genes-II | |
| 8 | Carcinogenesis | |
| 9 | Metastasis | |
| 10 | Tumor Immunology and Immunotherapy | |
| 11 | Targeted Therapy for Cancer and Clinical Phase Trials | |
| 12 | Stem Cell Therapeutics for Cancer | |
| 13 | Lipid Metabolism in Cancer |
| Resources |
| The Biology of Cancer-Robert Weinberg and lecture notes |
Course Contribution to Program Qualifications
| Course Contribution to Program Qualifications | |||||||
| No | Program Qualification | Contribution Level | |||||
| 1 | 2 | 3 | 4 | 5 | |||
| 1 | They develop a skill to access scientific information extensively by doing research on Molecular Medicine and Biotechnology and other related fields and to be able to evaluate, interpret and implement the obtained information | X | |||||
| 2 | They develop a skill to integrate and interpret information on various disciplines concerning practical fields of Molecular Medicine and Biotechnology. | X | |||||
| 3 | They are able to recognize the problems related to Molecular Medicine and Biotechnology field, develop methods for solving those problems, and they can implement the obtained information. | X | |||||
| 4 | They know the fundamental biostatistics approaches and methods. They are able to interpret scientific experimental data statistically. | ||||||
| 5 | They develop a skill to be aware of new and developing applications in the fields of Molecular Medicine and Biotechnology and use and teach them efficiently when necessary. | X | |||||
| 6 | They are able to access available scientific information on the literature related to Molecular Medicine and Biotechnology fields, interpret critically and use such information. | X | |||||
| 7 | They develop a skill to produce new and original ideas and methods. | X | |||||
| 8 | They use their theoretical knowledge and critical thinking ability in their field of study, evaluate and interpret the results, and writes the report of the study. | X | |||||
| 9 | They develop a skill to take the lead within teams doing healthcare studies, develop new ideas to solve complicated situations, and take responsibility. | ||||||
| 10 | They develop a skill to convey (whether in written form or orally) the scientific information obtained by them at national or international platforms in a systematic and open manner. | X | |||||
| 11 | They define a scientific or technical problem with the help of a consultant or individually, make suggestions for its solution and solve it when necessary. | X | |||||
| 12 | They develop the ability to act in accordance with ethical and professional principles at all stages of educational, practice, and research activities. They can evaluate the results obtained based on the quality criteria. | X | |||||
| 13 | They can supervise and teach the social, scientific, cultural, and ethical values in the stages of collecting, interpreting, applying, and announcing the data related to the field of Molecular Medicine and Biotechnology. | ||||||
Assessment Methods
| Contribution Level | Absolute Evaluation | |
| Rate of Midterm Exam to Success | 50 | |
| Rate of Final Exam to Success | 50 | |
| Total | 100 | |
| ECTS / Workload Table | ||||||
| Activities | Number of | Duration(Hour) | Total Workload(Hour) | |||
| Course Hours | 0 | 0 | 0 | |||
| Guided Problem Solving | 0 | 0 | 0 | |||
| Resolution of Homework Problems and Submission as a Report | 0 | 0 | 0 | |||
| Term Project | 0 | 0 | 0 | |||
| Presentation of Project / Seminar | 0 | 0 | 0 | |||
| Quiz | 0 | 0 | 0 | |||
| Midterm Exam | 0 | 0 | 0 | |||
| General Exam | 0 | 0 | 0 | |||
| Performance Task, Maintenance Plan | 0 | 0 | 0 | |||
| Total Workload(Hour) | 0 | |||||
| Dersin AKTS Kredisi = Toplam İş Yükü (Saat)/30*=(0/30) | 0 | |||||
| ECTS of the course: 30 hours of work is counted as 1 ECTS credit. | ||||||
Detail Informations of the Course
Course Description
| Course | Code | Semester | T+P (Hour) | Credit | ECTS |
|---|---|---|---|---|---|
| MOLECULAR ONCOLOGY | MMBY1211563 | Spring Semester | 2+0 | 2 | 6 |
| Course Program |
| Prerequisites Courses | |
| Recommended Elective Courses |
| Language of Course | English |
| Course Level | Second Cycle (Master's Degree) |
| Course Type | Elective |
| Course Coordinator | Assoc.Prof. Nihal KARAKAŞ |
| Name of Lecturer(s) | Assoc.Prof. Nihal KARAKAŞ, Assist.Prof. Yasemin YOZGAT BYRNE |
| Assistant(s) | |
| Aim | The aim of this course is to define and evaluate the fundamental concepts in cancer biology and therapy, understanding of the basis for cancer formation, progression and recurrence as well as learning about current and prospective therapies against cancers. |
| Course Content | This course contains; Introduction to cancer biology ,Oncogenes-I,Oncogenes-II,Signaling Factors and Cancer-I,Signaling Factors and Cancer-II,Tumor Suppressor Genes-I,Tumor Suppressor Genes-II,Carcinogenesis,Metastasis,Tumor Immunology and Immunotherapy,Targeted Therapy for Cancer and Clinical Phase Trials,Stem Cell Therapeutics for Cancer,Lipid Metabolism in Cancer. |
| Course Learning Outcomes | Teaching Methods | Assessment Methods |
| Defines the cancer, explain fundamentals of cancer, define and discuss the molecular basis of cancer, explain the current tretament strategies in cancer therapies, define and discuss the barriers in cancer therapies, analyze and discuss the new therapy approaches against cancers. | 10, 13, 14, 16, 19, 37, 9 | A, B, C, E, K |
| Teaching Methods: | 10: Discussion Method, 13: Case Study Method, 14: Self Study Method, 16: Question - Answer Technique, 19: Brainstorming Technique, 37: Computer-Internet Supported Instruction, 9: Lecture Method |
| Assessment Methods: | A: Traditional Written Exam, B: Short Answer Exam, C: Multiple-Choice Exam, E: Homework, K: Self Assessment Technique |
Course Outline
| Order | Subjects | Preliminary Work |
|---|---|---|
| 1 | Introduction to cancer biology | |
| 2 | Oncogenes-I | |
| 3 | Oncogenes-II | |
| 4 | Signaling Factors and Cancer-I | |
| 5 | Signaling Factors and Cancer-II | |
| 6 | Tumor Suppressor Genes-I | |
| 7 | Tumor Suppressor Genes-II | |
| 8 | Carcinogenesis | |
| 9 | Metastasis | |
| 10 | Tumor Immunology and Immunotherapy | |
| 11 | Targeted Therapy for Cancer and Clinical Phase Trials | |
| 12 | Stem Cell Therapeutics for Cancer | |
| 13 | Lipid Metabolism in Cancer |
| Resources |
| The Biology of Cancer-Robert Weinberg and lecture notes |
Course Contribution to Program Qualifications
| Course Contribution to Program Qualifications | |||||||
| No | Program Qualification | Contribution Level | |||||
| 1 | 2 | 3 | 4 | 5 | |||
| 1 | They develop a skill to access scientific information extensively by doing research on Molecular Medicine and Biotechnology and other related fields and to be able to evaluate, interpret and implement the obtained information | X | |||||
| 2 | They develop a skill to integrate and interpret information on various disciplines concerning practical fields of Molecular Medicine and Biotechnology. | X | |||||
| 3 | They are able to recognize the problems related to Molecular Medicine and Biotechnology field, develop methods for solving those problems, and they can implement the obtained information. | X | |||||
| 4 | They know the fundamental biostatistics approaches and methods. They are able to interpret scientific experimental data statistically. | ||||||
| 5 | They develop a skill to be aware of new and developing applications in the fields of Molecular Medicine and Biotechnology and use and teach them efficiently when necessary. | X | |||||
| 6 | They are able to access available scientific information on the literature related to Molecular Medicine and Biotechnology fields, interpret critically and use such information. | X | |||||
| 7 | They develop a skill to produce new and original ideas and methods. | X | |||||
| 8 | They use their theoretical knowledge and critical thinking ability in their field of study, evaluate and interpret the results, and writes the report of the study. | X | |||||
| 9 | They develop a skill to take the lead within teams doing healthcare studies, develop new ideas to solve complicated situations, and take responsibility. | ||||||
| 10 | They develop a skill to convey (whether in written form or orally) the scientific information obtained by them at national or international platforms in a systematic and open manner. | X | |||||
| 11 | They define a scientific or technical problem with the help of a consultant or individually, make suggestions for its solution and solve it when necessary. | X | |||||
| 12 | They develop the ability to act in accordance with ethical and professional principles at all stages of educational, practice, and research activities. They can evaluate the results obtained based on the quality criteria. | X | |||||
| 13 | They can supervise and teach the social, scientific, cultural, and ethical values in the stages of collecting, interpreting, applying, and announcing the data related to the field of Molecular Medicine and Biotechnology. | ||||||
Assessment Methods
| Contribution Level | Absolute Evaluation | |
| Rate of Midterm Exam to Success | 50 | |
| Rate of Final Exam to Success | 50 | |
| Total | 100 | |